NCT00636571

Brief Summary

Primary Objective: To examine the effects of an exercise training program on cardiopulmonary fitness in early-stage postoperative non-small cell lung cancer patients undergoing adjuvant chemotherapy Secondary Objectives: Determine patients' adherence levels to such a program during adjuvant chemotherapy Explore the effects of exercise training on treatment compliance and toxicity, and quality of life. To explore the effects of exercise training on markers of inflammation (e.g., c-reactive protein, immune response) in patients undergoing adjuvant chemotherapy for early-stage non-small cell lung cancer

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable nonsmall-cell-lung-cancer

Timeline
Completed

Started Mar 2006

Shorter than P25 for not_applicable nonsmall-cell-lung-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2006

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2007

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

February 27, 2008

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2008

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 14, 2008

Completed
Last Updated

October 28, 2013

Status Verified

October 1, 2013

Enrollment Period

1.5 years

First QC Date

February 27, 2008

Last Update Submit

October 25, 2013

Conditions

Keywords

ExerciseNon-Small Cell Lung CancerCardiopulmonary Fitness

Outcome Measures

Primary Outcomes (1)

  • ECG stress test

    8 weeks, 16 weeks

Secondary Outcomes (4)

  • Safety

    8 weeks, 16 weeks

  • adherence levels

    8 and 16 weeks

  • Treatment compliance and toxicity, and quality of life

    8 and 16 weeks

  • Inflammation

    8 and 16 weeks

Interventions

ExerciseBEHAVIORAL

Upright bike intervention for post-surgical lung cancer survivors.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Legal age (\>18 years old)
  • Absence of contraindications to chemotherapy
  • Ability to read and understand English
  • Signed informed consent prior to the initiation of study procedures
  • Primary attending oncologist approval.

You may not qualify if:

  • Acute myocardial infarction (3-5 days)
  • Unstable angina
  • Uncontrolled arrhythmias causing symptoms or hemodynamic compromise
  • Syncope
  • Acute endocarditis
  • Acute myocarditis or pericarditis
  • Uncontrolled heart failure
  • Acute pulmonary embolus or pulmonary infarction
  • Thrombosis of lower extremities
  • Suspected dissecting aneurysm
  • Uncontrolled asthma
  • Pulmonary edema
  • Room air desaturation at rest ≤85%
  • Respiratory failure
  • Acute noncardiopulmonary disorder that may affect exercise performance or be aggravated by exercise
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Health System Preston Robert Tisch Brain Tumor Center

Durham, North Carolina, 27710, United States

Location

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell LungMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Carcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Lee Jones, PhD

    Duke Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2008

First Posted

March 14, 2008

Study Start

March 1, 2006

Primary Completion

September 1, 2007

Study Completion

March 1, 2008

Last Updated

October 28, 2013

Record last verified: 2013-10

Locations